@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G7KXQWSR-5 skos:prefLabel "biosynthèse (Qualificatif)"@fr, "biosynthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-Z9TSGBXH-4 skos:prefLabel "génétique (Qualificatif)"@fr, "genetics (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D1MWFZGL-0 skos:prefLabel "Cystéine"@fr, "Cysteine"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-V7LSV2R7-9 . jvr:-CJXMKG5Q-F skos:prefLabel "deficiency (Qualifier)"@en, "déficit (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-V7LSV2R7-9 mesh:allowableQualifier jvr:-BT300B3G-Q, jvr:-T9HQD7ST-J, jvr:-Q3979798-W, jvr:-XV06LPML-W, jvr:-FWD2BGQ0-9, jvr:-WK5F724J-1, jvr:-S0CS1X5R-5, jvr:-CJXMKG5Q-F, jvr:-N2WP45CN-V, jvr:-G30ZJ446-J, jvr:-R3QWLHRG-V, jvr:-Z9TSGBXH-4, jvr:-G4R176S9-J, jvr:-WZF2ZR3L-B, jvr:-H7K65Q8S-Z, jvr:-HQRFT0C6-B, jvr:-NKM836P1-M, jvr:-G7KXQWSR-5, jvr:-TJHVZCRZ-0, jvr:-D0F21513-5, jvr:-NFTHND7Q-8, jvr:-W6SQV79N-S, jvr:-M63HSDM7-1, jvr:-L6C0XPHT-4, jvr:-NHL3D2X0-S, jvr:-R0ZCQ8X6-J, jvr:-CB30NGKB-3, jvr:-THHNVC7V-3, jvr:-SBNWSM1T-R, jvr:-NB0XHT3S-N ; a mesh:Descriptor, skos:Concept ; skos:prefLabel "Cysteinyldopa"@en, "5-((2-Amino-2-carboxyéthyl)sulfanyl)-3-hydroxy-tyrosine"@fr ; skos:altLabel "Cystéinyldopa"@fr, "5-S-Cysteinyldopa"@en, "19641-92-0"@fr, "19641-92-0"@en, "5-((2-Amino-2-carboxyéthyl)sulfanyl)-3-hydroxytyrosine"@fr, "L-Tyrosine, 3-((2-amino-2-carboxyethyl)thio)-5-hydroxy-, (R)-"@fr, "L-Tyrosine, 3-((2-amino-2-carboxyethyl)thio)-5-hydroxy-, (R)-"@en ; dc:created "1976-04-27"^^xsd:date ; skos:broader jvr:-NQ6H8MJ6-6, jvr:-D1MWFZGL-0 ; skos:inScheme jvr: ; dc:established "1991-01-01"^^xsd:date ; skos:definition "Found in large amounts in the plasma and urine of patients with malignant melanoma. It is therefore used in the diagnosis of melanoma and for the detection of postoperative metastases. Cysteinyldopa is believed to be formed by the rapid enzymatic hydrolysis of 5-S-glutathionedopa found in melanin-producing cells."@en ; dc:modified "2018-06-30"^^xsd:date ; owl:sameAs . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-N2WP45CN-V skos:prefLabel "drug effects (Qualifier)"@en, "effets des médicaments et des substances chimiques (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WZF2ZR3L-B skos:prefLabel "physiology (Qualifier)"@en, "physiologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NQ6H8MJ6-6 skos:prefLabel "Dopa"@fr, "Dihydroxyphenylalanine"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-V7LSV2R7-9 .